Tg Therapeutics (TGTX) Gross Profit (2021 - 2026)
Tg Therapeutics (TGTX) posted Gross Profit of $199.14 million for Q2 2026, up 62.9% from $122.21 million a year earlier and up 16.2% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Gross Profit (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Tg Therapeutics was $658.6 million, up 66.8% year-over-year; for FY2025, it was $515.57 million, up 77.5% from FY2024.
- Annual Gross Profit shows a four-year compound annual growth rate of 205.8% (FY2021 to FY2025).
- In prior years, Tg Therapeutics' Gross Profit was $290.52 million in FY2024 (+32.3%), $219.53 million in FY2023, $2.52 million in FY2022 (-57.3%) and $5.9 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Gross Profit in data going back to Q1 2021.
- On a year-over-year basis, Gross Profit has increased in each of the last seven quarters, with growth averaging 67.9% over the last eight quarters.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q1 2024, with growth of 735.5%; the weakest was Q3 2024, with a decline of 54.1%.
- According to Business Quant data, Gross Profit for the three prior quarters was $171.41 million (Q1 2026), $154.43 million (Q4 2025) and $133.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Tg Therapeutics | 9.71 Bn | 8.96 Bn | 217.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 217.86 Mn |
| Jun 30, 2026 | 199.14 Mn |
| Mar 31, 2026 | 171.41 Mn |
| Dec 31, 2025 | 154.43 Mn |
| Sep 30, 2025 | 133.62 Mn |
| Jun 30, 2025 | 122.21 Mn |
| Mar 31, 2025 | 105.32 Mn |
| Dec 31, 2024 | 92.79 Mn |
| Sep 30, 2024 | 74.54 Mn |
| Jun 30, 2024 | 65.16 Mn |
| Mar 31, 2024 | 58.03 Mn |
| Dec 31, 2023 | 36.12 Mn |
| Sep 30, 2023 | 162.31 Mn |
| Jun 30, 2023 | 14.16 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 77,000.00 |
| Sep 30, 2022 | 92,000.00 |
| Jun 30, 2022 | 571,000.00 |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 2.11 Mn |
API Access
Tg Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();